Globe Life Inc. (NYSE:GL – Get Free Report) CFO Thomas Peter Kalmbach sold 11,903 shares of Globe Life stock in a transaction on Tuesday, May 19th. The shares were sold at an average price of $156.61, for a total value of $1,864,128.83. Following the sale, the chief financial officer directly owned 48,432 shares of the company’s stock, valued at approximately $7,584,935.52. The trade was a 19.73% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Thomas Peter Kalmbach also recently made the following trade(s):
- On Friday, May 8th, Thomas Peter Kalmbach sold 11,790 shares of Globe Life stock. The shares were sold at an average price of $152.02, for a total value of $1,792,315.80.
- On Monday, May 11th, Thomas Peter Kalmbach sold 15,637 shares of Globe Life stock. The stock was sold at an average price of $153.65, for a total value of $2,402,625.05.
Globe Life Price Performance
Shares of NYSE:GL opened at $154.65 on Thursday. Globe Life Inc. has a fifty-two week low of $116.73 and a fifty-two week high of $157.92. The business has a 50-day moving average of $146.66 and a two-hundred day moving average of $141.63. The stock has a market capitalization of $12.01 billion, a P/E ratio of 10.70 and a beta of 0.50. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07.
Globe Life Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be paid a $0.33 dividend. The ex-dividend date is Monday, July 6th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.9%. Globe Life’s payout ratio is presently 9.13%.
Analyst Ratings Changes
GL has been the topic of a number of recent analyst reports. Keefe, Bruyette & Woods reiterated a “moderate buy” rating and issued a $168.00 price objective on shares of Globe Life in a research note on Thursday, March 26th. Weiss Ratings raised shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research report on Wednesday, May 13th. Texas Capital raised shares of Globe Life to a “strong-buy” rating in a research report on Wednesday, March 18th. Piper Sandler raised shares of Globe Life to a “strong-buy” rating in a research report on Thursday, April 2nd. Finally, Wells Fargo & Company boosted their target price on shares of Globe Life from $171.00 to $172.00 and gave the stock an “overweight” rating in a research report on Friday, April 10th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, Globe Life presently has an average rating of “Buy” and a consensus target price of $172.67.
Check Out Our Latest Analysis on Globe Life
Hedge Funds Weigh In On Globe Life
Several large investors have recently added to or reduced their stakes in GL. Allianz Asset Management GmbH raised its stake in Globe Life by 55.2% during the 3rd quarter. Allianz Asset Management GmbH now owns 82,263 shares of the company’s stock worth $11,761,000 after buying an additional 29,256 shares during the period. Retirement Systems of Alabama acquired a new stake in shares of Globe Life in the third quarter valued at about $2,470,000. Pzena Investment Management LLC increased its position in shares of Globe Life by 5.6% in the third quarter. Pzena Investment Management LLC now owns 998,506 shares of the company’s stock valued at $142,756,000 after acquiring an additional 52,523 shares during the last quarter. SG Americas Securities LLC increased its position in shares of Globe Life by 909.6% in the fourth quarter. SG Americas Securities LLC now owns 99,746 shares of the company’s stock valued at $13,950,000 after acquiring an additional 89,866 shares during the last quarter. Finally, Rakuten Investment Management Inc. acquired a new stake in shares of Globe Life in the third quarter valued at about $9,064,000. Institutional investors and hedge funds own 81.61% of the company’s stock.
Globe Life Company Profile
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Read More
- Five stocks we like better than Globe Life
- TJX Companies Fires on All Cylinders With 9% Revenue Growth
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
